Prelude Therapeutics (PRLD)
Prelude Therapeutics Statistics
Share Statistics
Prelude Therapeutics has 56.46M shares outstanding. The number of shares has increased by 0.41% in one year.
| 56.46M |
| 0.41% |
| 0.22% |
| 42.4% |
| n/a |
| 9,725 |
| 5.39% |
Short Selling Information
The latest short interest is 877.74K, so 1.55% of the outstanding shares have been sold short.
| 877.74K |
| 1.55% |
| 11.89% |
| 7.9 |
Valuation Ratios
The PE ratio is -0.76 and the forward PE ratio is -0.86. Prelude Therapeutics's PEG ratio is 0.04.
| -0.76 |
| -0.86 |
| 13.75 |
| 0.5 |
| 0.73 |
| -0.93 |
| 0.04 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Prelude Therapeutics.
| n/a |
| n/a |
| n/a |
| n/a |
Financial Position
The company has a current ratio of 5.3, with a Debt / Equity ratio of 0.14.
| 5.3 |
| 5.3 |
| 0.14 |
| -0.13 |
| -0.17 |
| 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| n/a |
| n/a |
| n/a |
| $53,435.11 |
| $-970,786.26 |
| 131 |
| 0.04 |
| n/a |
Taxes
| n/a |
| 0% |
Stock Price Statistics
The stock price has increased by -74.8% in the last 52 weeks. The beta is 1.24, so Prelude Therapeutics's price volatility has been higher than the market average.
| 1.24 |
| -74.8% |
| 0.83 |
| 1.53 |
| 59.63 |
| 180,446 |
Income Statement
In the last 12 months, Prelude Therapeutics had revenue of 7M and earned -127.17M in profits. Earnings per share was -1.68.
| 7M |
| 5.23M |
| -139.71M |
| -127.17M |
| -139.71M |
| -139.71M |
| -1.68 |
Balance Sheet
The company has 12.47M in cash and 18.02M in debt, giving a net cash position of -5.55M.
| 12.47M |
| 18.02M |
| -5.55M |
| -583.56M |
| 141.26M |
| 82.62M |
Cash Flow
In the last 12 months, operating cash flow was -102.89M and capital expenditures -764K, giving a free cash flow of -103.65M.
| -102.89M |
| -764K |
| -103.65M |
| -1.37 |
Margins
Gross margin is 74.69%, with operating and profit margins of -1995.91% and -1816.76%.
| 74.69% |
| -1995.91% |
| -1816.76% |
| -1816.76% |
| -1995.91% |
| -1995.91% |
| -1480.74% |
Dividends & Yields
PRLD does not appear to pay any dividends at this time.
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Analyst Forecast
The average price target for PRLD is $4, which is 321.1% higher than the current price. The consensus rating is "Buy".
| $4 |
| 321.1% |
| Buy |
| 3 |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| n/a |
| n/a |
| n/a |
| n/a |
Scores
| -7.82 |
| 3 |